* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Biovail Corp.

Biovail facing shareholder suit

A group of American investors has launched a class-action lawsuit against drug maker Biovail Corp., alleging the company and some executives made misleading statements during the approval process for the anti-depressant drug...

Biovail faces lawsuit over depression drug

NEW YORK - Canadian drug developer Biovail Corp. said Thursday it is being sued by investors who allege it made misleading statements during the approval process for the depression drug Aplenzin. The lawsuit, filed in U.S....

Class action securities suit filed against Biovail

BOSTON (MarketWatch) -- Biovail Corp. said early Thursday that a securities class action suit has been filed against the company in U.S. District Court Southern District of New York. The suit, which also names Biovail's...

InPlay: Mylan Labs reconfirmed guidance of a FY08 weighted average cost of financing of...

8:47AM Krispy Kreme awards franchise development rights for Shanghai, Beijing and Tianjin, China 2.50 : Co announced that it has entered into an agreement with KKD Lotte Holdings Co for the development of approximately 35...

CN ON: Just Don't Call It Pot

Pubdate: Tue, 07 Oct 2008 Source: National Post (Canada) Copyright: 2008 Canwest Publishing Inc. Contact: http://www.nationalpost.com/ Details: http://www.mapinc.org/media/286 Author: David Dias, Financial Post Magazine...

Biovail Gains Newly Approved HD Drug in $100M Prestwick Buyout

A month after winning FDA approval for its first drug, privately held Prestwick Pharmaceuticals Inc. was acquired by Canadian drugmaker Biovail Corp. in a $100 million deal. The transaction gives Toronto-based Biovail...

Losses pile up on stock markets in wake of Fed rescue of insurer AIG

By: Malcolm Morrison, THE CANADIAN PRESS TORONTO - New York indexes were also in the dumps after the Fed provided a US$85-billion loan to AIG in exchange for an 80 per cent stake in the company, which faces billions in...

Biovail Seeks FDA Approval For Generic Version Of Abbott Laboratories Cholesterol Drug

September 4, 2008 (FinancialWire) -- Canadian drugmaker Biovail Corp. (NYSE: BVF) said that it is seeking U.S. approval to market a generic version of cholesterol drug Tricor from Abbott Laboratories (NYSE: ABT). Biovail...